Rubinstein Linda M Insider Trades

Insider Trading History

Track insider trading activity for Rubinstein Linda M. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Adverum Biotechnologies
Adverum Biotechnologies ADVM
CHIEF FINANCIAL OFFICER
Holding Value $267k 61,150 shares
Last Trade
Dec 09, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$205k 48,750 shares
$4.20
$4.36
Adverum Biotechnologies
Adverum Biotechnologies ADVM
CHIEF FINANCIAL OFFICER
Holding Value $183k 42,000 shares
Last Trade
Dec 09, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$183k 42,000 shares
$4.36
$4.36
Adverum Biotechnologies
Adverum Biotechnologies ADVM
CHIEF FINANCIAL OFFICER
Holding Value $0 0 shares
Last Trade
Dec 09, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$641k 147,083 shares
$4.36
$4.36
Adverum Biotechnologies
Adverum Biotechnologies ADVM
CHIEF FINANCIAL OFFICER
Holding Value $0 0 shares
Last Trade
Dec 09, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$205k 48,750 shares
$4.20
$4.36
Adverum Biotechnologies
Adverum Biotechnologies ADVM
CHIEF FINANCIAL OFFICER
Holding Value $0 0 shares
Last Trade
Dec 09, 2025 Sale (Tender)Reported as Tender on SEC Form 4.
$485k 111,275 shares
$4.36
$4.36
Adverum Biotechnologies
Adverum Biotechnologies ADVM
CHIEF FINANCIAL OFFICER
Holding Value $371k 85,000 shares
Last Trade
Jun 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$278k 120,000 shares
$2.32
$4.36
Adverum Biotechnologies
Adverum Biotechnologies ADVM
CHIEF FINANCIAL OFFICER
Holding Value $0 0 shares
Last Trade
Jun 17, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$278k 120,000 shares
$2.32
$4.36
Adverum Biotechnologies
Adverum Biotechnologies ADVM
CHIEF FINANCIAL OFFICER
Holding Value $213k 48,750 shares
Last Trade
Feb 25, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$205k 48,750 shares
$4.20
$4.36
Adverum Biotechnologies
Adverum Biotechnologies ADVM
CHIEF FINANCIAL OFFICER
Holding Value $271k 62,083 shares
Last Trade
Aug 02, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$444k 62,083 shares
$7.15
$4.36
Adverum Biotechnologies
Adverum Biotechnologies ADVM
CHIEF FINANCIAL OFFICER
Holding Value $1.53M 350,000 shares
Last Trade
Feb 12, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$697k 350,000 shares
$1.99
$4.36
Adverum Biotechnologies
Adverum Biotechnologies ADVM
Chief Financial Officer
Holding Value $3.71M 850,000 shares
Last Trade
Aug 03, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.79M 850,000 shares
$2.10
$4.36
Adverum Biotechnologies
Adverum Biotechnologies ADVM
Chief Financial Officer
Holding Value $436k 100,000 shares
Last Trade
Jun 07, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$145k 100,000 shares
$1.45
$4.36
Biocept
Biocept BIOC
Director
Holding Value $4.35k 10,000 shares
Last Trade
Jul 08, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.3k 10,000 shares
$1.03
$0.43
Biocept
Biocept BIOC
Director
Holding Value $4.35k 10,000 shares
Last Trade
Jul 16, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$37.7k 10,000 shares
$3.77
$0.43

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up